IGF1 and lymphangioma: Another proteomics study, reported by Smalley et al., analyzed 45 CSF samples from 16 melanoma LM patients by mass spectrometry and RNA sequencing, showing that CSF from most LM patients was highly enriched in pathways involved in damage mediated by protease, IGF-mediated signaling and innate immunity.